Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. V. Reshet’ko
Comparative Evaluation of the Long-Term Efficacy and Safety of the Infliximab Biosimilar BCD-055 and Reference Infliximab in Patients With Ankylosing Spondylitis: Results of the International Multicenter Randomized Double-Blind Phase Iii Clinical Study Asart-2
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Long-Term Safety and Efficacy of Tocilizumab in Patients With Early Rheumatoid Arthritis of Moderate or High Activity (Results of Phase Iii Multicenter Extension Clinical Study Ml28124)
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Related publications
Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis
Arthritis Research & Therapy
Efficacy, Safety, and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: A Randomized, Double-Blind Phase 3 Study, MEASURE 3
Arthritis Research & Therapy
Management of Ankylosing Spondylitis With Infliximab
Open Access Rheumatology: Research and Reviews
Rheumatology
A Phase III Randomized Study to Evaluate the Efficacy and Safety of CT-P13 Compared With Reference Infliximab in Patients With Active Rheumatoid Arthritis: 54-Week Results From the PLANETRA Study
Arthritis Research & Therapy
Withdrawal of Infliximab Therapy in Ankylosing Spondylitis in Persistent Clinical Remission, Results From the REMINEA Study
Arthritis Research & Therapy
Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice
International Journal of Rheumatic Diseases
Rheumatology
FKB327, an Adalimumab Biosimilar, Versus the Reference Product: Results of a Randomized, Phase III, Double-Blind Study, and Its Open-Label Extension
Arthritis Research & Therapy
THU0218 the Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results From the Turkbio Registry
Effects of Etanercept and Infliximab on Bone Metabolism Indexes in Patients With Ankylosing Spondylitis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
